Figure - uploaded by Mehmet Işık
Content may be subject to copyright.
Contexts in source publication
Context 1
... treatment was not performed in the presence of any of these risk factors. Case data (age, BMI, complication formation, comorbid disease and habits) were acquired from file records and hospital software system (Table 1). Study approval (2021 / 3215) was obtained from the Local Ethics Committee and written informed patient consent was obtained from each patient. ...Context 2
... number of patients with ASA score I was 67 (77,1%), and the number of patients with II was 20 (%22,9). Other demographical data are available in Table 1. Four patients (%4,5) had postoperative complications. ...Context 3
... operation duration was detected as 153±41.3 min (Table 1). None of the patients was taken in revision due to bleeding. ...Context 4
... treatment was not performed in the presence of any of these risk factors. Case data (age, BMI, complication formation, comorbid disease and habits) were acquired from file records and hospital software system (Table 1). Study approval (2021 / 3215) was obtained from the Local Ethics Committee and written informed patient consent was obtained from each patient. ...Context 5
... number of patients with ASA score I was 67 (77,1%), and the number of patients with II was 20 (%22,9). Other demographical data are available in Table 1. Four patients (%4,5) had postoperative complications. ...Citations
... Venous thromboembolism (VTE) is a complication that could be seen as a result of multifactorial events. Venous stasis, increased coagulation, and endothelial damage play a role in the pathophysiology of VTE and are known as Virchow's triad [7]. The most important of the three factors is venous stasis. ...
Venous thromboembolism (VTE) is an important complication observed in patients with chronic liver diseases. This study aims to present demographics and some clinical characteristics of patients with chronic liver disease (CLD) with an emphasis on the development of venous thromboembolism. The study was conducted with the data of patients having chronic liver disease who were admitted to Inonu University Turgut Özal Medical Center Liver Transplant Institute. 63 patients diagnosed with chronic liver diseases were included in the study. Chronic liver disease patients were confirmed according to the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Positive Doppler ultrasonography, computed tomography, or angiographic study documentation were used to confirm the presence of thrombosis. In conclusion, although patients with CLD are traditionally prone to bleeding disorders, VTE is also a serious complication in these patients. Therefore, it should be considered that anticoagulation treatment should be provided to all CLD patients with verified VTE.
